Overview
Suzanne Gagnon is a primary care provider, practicing in Internal Medicine in North Wales, Pennsylvania.
Her clinical expertise encompasses Pancreatic Ductal Adenocarcinoma.
She is actively involved in clinical research, co-authoring 3 peer reviewed articles.
Specialties
Licenses
Languages Spoken
Gender
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- HMO
- EPO
- HMO
- POS
- PPO
Locations
212 Church Rd, North Wales, PA 19454
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Temple University Hospital
Henry Parkman is an Internal Medicine provider practicing medicine in Philadelphia, Pennsylvania. He has been practicing medicine for over 44 years. Dr. Parkman is highly rated in 21 conditions, according to our data. His clinical expertise encompasses Gastroparesis, Gastroesophageal Reflux Disease (GERD), Gastric Dysmotility, Gastrectomy, and Endoscopy.
Temple University Hospital
Wei Zhao is a primary care provider, practicing in Internal Medicine in Philadelphia, Pennsylvania. Dr. Zhao is highly rated in 143 conditions, according to our data. His clinical expertise encompasses Microsporidiosis, Lung Cancer, Lung Adenocarcinoma, Coronary Artery Bypass Graft (CABG), and Endoscopy.
Penn Endocrine And Oncologic Surgery Perelman 3RD Floor
David Metz is an Internal Medicine provider practicing medicine in Philadelphia, Pennsylvania. Dr. Metz is highly rated in 13 conditions, according to our data. His clinical expertise encompasses Neuroendocrine Tumor, Zollinger-Ellison Syndrome, Pancreatic Islet Cell Tumor, Endoscopy, and Colonoscopy.
Frequently Asked Questions about Dr. Suzanne Gagnon
How do I make an appointment with Dr. Suzanne Gagnon?
You can book an appointment with Dr. Suzanne Gagnon by calling their office at 215-616-3688. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.
Is Dr. Suzanne Gagnon a top-rated expert for Pancreatic Ductal Adenocarcinoma?
MediFind is an objective health platform that identifies experts based on real-world data. Dr. Suzanne Gagnon is classified as an Experienced expert for Pancreatic Ductal Adenocarcinoma, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
What conditions does Dr. Suzanne Gagnon specialize in?
While Dr. Suzanne Gagnon is a Internal Medicine, they have specific expertise in Pancreatic Ductal Adenocarcinoma. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Internal Medicine.
Does Dr. Suzanne Gagnon participate in research or clinical trials?
Yes. Dr. Suzanne Gagnon has published 3 articles and abstracts on conditions like Pancreatic Ductal Adenocarcinoma. You can view a list of Dr. Suzanne Gagnon's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Does Dr. Suzanne Gagnon accept my insurance?
Dr. Suzanne Gagnon accepts most major insurance plans, including Tufts and UnitedHealthcare. We recommend calling the office directly at 215-616-3688 to verify that your specific plan is currently accepted before your visit.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- Pancreatic Ductal AdenocarcinomaDr. Gagnon isExperienced. Learn about Pancreatic Ductal Adenocarcinoma.